Abstract:Hereditary spastic paraplegia (HSP) associated with thin corpus callosum (TCC) is an autosomal recessive complicated HSP characterized by normal motor development, followed by slowly progressive spastic paraparesis and mental deterioration. Recently, mutations of the SPG11 gene encoding the spatacsin protein have been identified as a major cause of HSP-TCC. SPG11 is located on chromosome 15q21.1, contains 40 exons and encodes a protein of 2,443 amino acids. Spatacsin function is not yet known, however, its widespread expression in the central nervous system and its highly conserved sequence among species indicate an important and essential role. Up to date, 10 mutations including four nonsense mutations, four small deletions and two small insertions of the SPG11 gene were found in 12 families of ARHSP-TCC. Here, we described two novel mutations of the SPG11 gene in two unrelated Chinese patients with HSP-TCC. Patient 1, a 24-year-old man, presented with a progressive speech disorder with mental deterioration impairing school performance(s) from the age of 7 years on. From the age of 14 onwards, he also developed leg stiffness and gait disturbance. There was no consanguinity, family history was unremarkable, and his birth and motor development had been normal. Neurologic examination at age 24 showed dysarthria, left foot muscle atrophy, lower limb symmetric spasticity, upper limb ataxia, and unsteady tandem walking. His Mini Mental State Examination (MMSE) score was 14/30. Ceruloplasmin was normal. Motor nerve conduction of the left peroneal nerve showed lowered amplitude. EMG examination showed denervation potentials in the anterior tibial muscles and the left gastrocnemius muscle. Brain MR Images (Fig 1a–c) disclosed thinning of the corpus callosum, especially in its anterior parts, slight hyperintense signal alterations in the periventricular white matter, as well as mild thalamic and cerebellar atrophy. Spinal cord MRI was normal. Patient 2, a 26-year-old man, born from consanguineous parents, suffered from slowly progessive dysarthria, accompanied by a gait disorder from the age of 18 onwards. He had difficulty in walking without assistance by the age of 23. His MMSE score was 6/30. Besides the dysarthria, and paraspasticity, there was additional hand muscle atrophy, and mild weakness of the lower limbs. Nerve conduction was normal. In the brain MRI (Fig 1d–f) there was slight enlargement of the lateral ventricles and a thin corpus callosum. Spine MRI revealed atrophy of the thoracic cord. Some of the dysarthria and spasticity symptoms of the patients improved under treatment with baclofen (45 mg/day) and D2 receptor agonist (Piribedil, 50 mg bid). Sequencing of the SPG11 gene revealed a novel homozygous small deletion (c.4307_4308del, Fig. 2A) in exon 25 in the first patient leading to a frameshift and early termination at amino acid residue 1,442. This was not found in 100 control chromosomes studied by direct sequencing (Fig. 2B). A homozygous c.5977C>T substitution was found in exon 31 in the second patient (Fig. 2C), leading to a termination at amino acid residue 1,993. All PCR products of exon 31 of 50 healthy controls were cut into 210 bp and 320 bp with Sall (Fig. 2E). This restriction site which is found in normal chromosomes was lost in patient 2. A homozygous c.833A>G substitution was also detected in exon 5 of the same patient (Fig. 2F), leading to an amino acid change (p.278N>S). This is likely a polymorphism since 4 out of 50 healthy controls were heterozygote for the same change (Fig. 2G). The two novel mutations found in the present report lead to a stop codon, providing further evidence for a loss of function mechanism. The difference of the severity and onset age of these two patients may be due to differences in spatacsin dysfunction resulting from the two mutations. However, a precise genotype-phenotype correlation is not yet possible, due to the small overall number of patients with SPG11 mutations described so far. This report points to the importance of screening the SPG11 gene for additional mutations in more families with HSP-TCC.

COQ7 splice site variant causing a spastic paraparesis phenotype in siblings

Homozygous Variant in COQ7 Causes Autosomal Recessive Hereditary Spastic Paraplegia.

Biallelic Variants in the COQ4 Gene Caused Hereditary Spastic Paraplegia Predominant Phenotype.

Genetic Spectrum of MCM3AP and Its Relationship with Phenotype of Charcot‐Marie‐Tooth Disease

SPTAN1 Variants Likely Cause Autosomal Recessive Complicated Hereditary Spastic Paraplegia

Biallelic variants in COQ7 cause distal hereditary motor neuropathy with upper motor neuron signs

Biallelic COQ4 Variants in Hereditary Spastic Paraplegia: Clinical and Molecular Characterization

COQ7 defect causes prenatal onset of mitochondrial CoQ 10 deficiency with cardiomyopathy and gastrointestinal obstruction

A Family Segregating Lethal Primary Coenzyme Q10 Deficiency Due to Two Novel COQ6 Variants

No Genetic Evidence for the Association Between COQ7 and Chinese Patients with Amyotrophic Lateral Sclerosis

Identification and analyses of exonic and copy number variants in spastic paraplegia

A respiratory/Hirschsprung phenotype in a three-generation family associated with a novel pathogenic PHOX2B splice donor mutation

Deep intronic variant causes aberrant splicing of ATP7A in a family with a variable occipital horn syndrome phenotype

Two Novel Mutations in the SPG11 Gene Causing Hereditary Spastic Paraplegia Associated with Thin Corpus Callosum

A Novel MAG Variant Causes Hereditary Spastic Paraplegia in a Consanguineous Pakistani Family

A missense variant in EXOSC8 causes exon skipping and expands the phenotypic spectrum of pontocerebellar hypoplasia type 1C

Biallelic variants in cause a mitochondrial disorder primarily manifesting as peripheral neuropathy

A homozygous variant in CHMP3 is associated with complex hereditary spastic paraplegia

<i>COQ2</i> mutation associated isolated nephropathy in two siblings from a Chinese pedigree

In silico characterization and identification of compound heterozygous variants in H/ACA Ribonucleoprotein Assembly Factor (SHQ1) from Indian population

A novel inborn error of the coenzyme Q10 biosynthesis pathway: cerebellar ataxia and static encephalomyopathy due to COQ5 C‐methyltransferase deficiency